Clinical trial
Cerebrovascular Reactivity and Oxygen Metabolism as Markers of Neurodegeneration After Traumatic Brain Injury
NCT04820881 is registered in ClinicalTrials.gov with Washington D.C. Veterans Affairs Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cerebrovascular Reactivity and Oxygen Metabolism as Markers of Neurodegeneration After Traumatic Brain Injury
- Lead sponsor
- Washington D.C. Veterans Affairs Medical Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 1, 2021
- Completion date
- September 30, 2024
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.